Commercializing biomedical research through securitization techniques
作者： Jose-Maria Fernandez , Roger M Stein , Andrew W Lo
DOI: 10.1038/NBT.2374
关键词:
摘要: … to financing biomedical innovation. Companies like Royalty Pharma (New York), Cowen Healthcare (Stamford, CT, USA) and DRI Capital (Toronto) are investment vehicles that acquire …
nature.com
core.ac.uk
rogermstein.com 参考文章(39)
Bart Meyns, Stefan Klotz, Andre Simon, Walter Droogne, Filip Rega, Bartley Griffith, Robert Dowling, Mark J. Zucker, Daniel Burkhoff, Proof of Concept Journal of the American College of Cardiology. ,vol. 54, pp. 79- 86 ,(2009) , 10.1016/J.JACC.2009.04.023
Deborah Lucas, Robert McDonald, Valuing Government Guarantees: Fannie and Freddie Revisited Research Papers in Economics. pp. 131- 154 ,(2010)
Roger M. Stein, Jeffrey R. Bohn, Active Credit Portfolio Management in Practice ,(2009)
G. Felda Hardymon, Joshua Lerner, Ann Leamon, Venture capital, private equity, and the financing of entrepreneurship : the power of active investing John Wiley & Sons. ,(2012)
Gary P. Pisano, Science Business: The Promise, the Reality, and the Future of Biotech ,(2006)
Scott E. Harrington, Cost of Capital for Pharmaceutical, Biotechnology, and Medical Device Firms Social Science Research Network. pp. 75- ,(2012) , 10.1093/OXFORDHB/9780199742998.013.0004
Kenneth S. Rogoff, Carmen M. Reinhart, This Time Is Different: Eight Centuries of Financial Folly ,(2009)
Deborah Lucas, Measuring and Managing Federal Financial Risk Research Papers in Economics. ,(2010) , 10.7208/CHICAGO/9780226496597.001.0001
Andrew W. Lo, Reading About the Financial Crisis: A 21-Book Review Social Science Research Network. ,(2011) , 10.2139/SSRN.1949908
Alastair J.J. Wood, Progress and Deficiencies in the Registration of Clinical Trials The New England Journal of Medicine. ,vol. 360, pp. 824- 830 ,(2009) , 10.1056/NEJMSR0806582